Epstein-Barr Virus (EBV) latent membrane protein 1 (LMP1) peptides as inducers of regulatory cells to treat autoimmune haemolytic anaemia
Immune responses to Epstein-Barr Virus (EBV) encoded Latent Membrane Protein 1 (LMP1) peptides in seropositive donors are dominated by the induction of IL-10 secretion. These IL-10 responses, characteristic of T regulatory 1 (Tr1) cells, were able to inhibit T-cell proliferation and interferon-γ (IF...
Main Author: | Zamzami, Omar M. |
---|---|
Published: |
University of Aberdeen
2009
|
Subjects: | |
Online Access: | http://ethos.bl.uk/OrderDetails.do?uin=uk.bl.ethos.509153 |
Similar Items
-
Soro-epidemiologia do virus de Epstein-Barr (VEB) The seroepidemiology of the Epstein-Barr vírus (EBV)
by: Claudio Sergio Pannuti
Published: (1981-02-01) -
Epstein-Barr Functional Mimicry: Pathogenicity of Oncogenic Latent Membrane Protein-1 in Systemic Lupus Erythematosus and Autoimmunity
by: Melissa E. Munroe, et al.
Published: (2021-02-01) -
Observations on haemolytic disease
by: Richmond, J.
Published: (1963) -
CORRELATION BETWEEN IMMUNOLOGICAL HYPERSENSITIVITY AND EPSTEIN-BARR VIRUS IN PATHOGENESIS OF CHRONIC EBV.
by: Kanan, Moien Nihad.
Published: (1984) -
Adoptive immunotherapy for Epstein-Barr Virus-Associated Post-Transplant Lymphoproliferative Disease
by: Johannessen, Ingólfur
Published: (2007)